GlaxoSmithKline Pharma reports consolidated net loss of Rs 55 crore

GlaxoSmithKline Pharmaceuticals on Monday reported a consolidated net loss of Rs 55 crore from continuing operations for the March quarter (Q4FY22). The drug firm had reported a net profit of Rs 4 crore for Q4FY21.

Revenue from operations rose to Rs 810 crore for the fourth quarter, compared with Rs 744 crore in the year-ago period, the pharmaceutical major said in a regulatory filing.

For the financial year ended March 31, 2022, the company posted a consolidated net profit from continuing operations at Rs 381 crore, against Rs 287 crore in FY21.